164 related articles for article (PubMed ID: 24186592)
1. Chromogranin A (CgA) in adrenal tumours.
Glinicki P; Jeske W; Bednarek-Papierska L; Kasperlik-Załuska A; Rosłonowska E; Gietka-Czernel M; Zgliczyński W
Endokrynol Pol; 2013; 64(5):358-62. PubMed ID: 24186592
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
Giovanella L; Squin N; Ghelfo A; Ceriani L
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy inpatients with adrenal incidentalomas.
Giovanella L; Ceriani L; Balerna M; Keller F; Taborelli M; Marone C; Ferone D
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):84-88. PubMed ID: 17538521
[TBL] [Abstract][Full Text] [Related]
4. Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males.
Glinicki P; Jeske W; Kapuścińska R; Zgliczyński W
Endokrynol Pol; 2015; 66(1):53-6. PubMed ID: 25754282
[TBL] [Abstract][Full Text] [Related]
5. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
6. Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses.
Giovanella L
Anticancer Res; 2005; 25(3A):1547-50. PubMed ID: 16033058
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma.
Bílek R; Šafařík L; Ciprová V; Vlcek P; Lisá L
Physiol Res; 2008; 57 Suppl 1():S171-S179. PubMed ID: 18271679
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.
Ramachandran R; Bech P; Murphy KG; Caplin ME; Patel M; Vohra S; Khan MS; Dhillo WS; Sharma R; Palazzo FF; Win Z; Tan T; Khoo B; Meeran K; Frilling A; Ghatei MA; Bloom SR; Martin NM
J Clin Endocrinol Metab; 2015 Apr; 100(4):1520-8. PubMed ID: 25664601
[TBL] [Abstract][Full Text] [Related]
9. Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.
Giovanella L; Ceriani L
Int J Biol Markers; 2002; 17(2):130-4. PubMed ID: 12113580
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Václavíková E; Widimský J
Physiol Res; 2017 Sep; 66(Suppl 3):S397-S408. PubMed ID: 28948824
[TBL] [Abstract][Full Text] [Related]
11. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
12. High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma.
Cotesta D; Caliumi C; Alò P; Petramala L; Reale MG; Masciangelo R; Signore A; Cianci R; D'Erasmo E; Letizia C
Tumori; 2005; 91(1):53-8. PubMed ID: 15850005
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
14. The differences in chromogranin A (CgA) concentrations measured in serum and in plasma by IRMA and ELISA methods.
Glinicki P; Kapuścińska R; Jeske W
Endokrynol Pol; 2010; 61(4):346-50. PubMed ID: 20806177
[TBL] [Abstract][Full Text] [Related]
15. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
Feng C; Li HZ; Yan WG; Luo YF; Cao JL
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
[TBL] [Abstract][Full Text] [Related]
16. The role of chromogranin A in the management of patients with phaeochromocytoma.
Grossrubatscher E; Dalino P; Vignati F; Gambacorta M; Pugliese R; Boniardi M; Rossetti O; Marocchi A; Bertuzzi M; Loli P
Clin Endocrinol (Oxf); 2006 Sep; 65(3):287-93. PubMed ID: 16918946
[TBL] [Abstract][Full Text] [Related]
17. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
Rao F; Keiser HR; O'Connor DT
Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
[TBL] [Abstract][Full Text] [Related]
18. Processing-independent quantitation of chromogranin a in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas.
Børglum T; Rehfeld JF; Drivsholm LB; Hilsted L
Clin Chem; 2007 Mar; 53(3):438-46. PubMed ID: 17259235
[TBL] [Abstract][Full Text] [Related]
19. Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study.
Bülow B; Ahrén B;
J Intern Med; 2002 Sep; 252(3):239-46. PubMed ID: 12270004
[TBL] [Abstract][Full Text] [Related]
20. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D
Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
